HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical significance of early-onset hyperuricemia in renal transplant recipients.

AbstractBACKGROUND/AIMS:
It is undetermined whether the effect of uric acid (UA) on graft outcome is independent of graft dysfunction. This study was designed to explore whether early-onset hyperuricemia has clinical significance regardless of graft function.
METHODS:
This study was conducted based on a retrospective chart review. We calculated time-averaged UA and estimated glomerular filtration rate from the values at 3, 6, and 9 months after transplantation. Cardiovascular complications during follow-up and long-term graft survival were assessed according to UA levels and graft function.
RESULTS:
351 patients were enrolled into this study. Hyperuricemia increased the risk of cardiovascular complications (HR = 2.8, 95% CI 1.1-7.1; p = 0.02), but reduced graft function did not. In the hyperuricemia group, 5- and 10-year graft survival was significantly lower than in the normouricemia group (89 and 81% vs. 96 and 92%, respectively; p = 0.02). In the reduced graft function group, these values were also lower than in the normal graft function group (89 and 81% vs. 96 and 93%, respectively; p = 0.02). In the multivariate analysis, both hyperuricemia and reduced graft function were independent risk factors for graft failure and the presence of both factors presented the highest risk.
CONCLUSION:
Early-onset hyperuricemia is a significant predictor of cardiovascular complications and graft survival independently of graft function.
AuthorsByung Ha Chung, Seok Hui Kang, Hyeon Seok Hwang, Bum Soon Choi, Cheol Whee Park, Yong-Soo Kim, Ji-Il Kim, In Sung Moon, Chul Woo Yang
JournalNephron. Clinical practice (Nephron Clin Pract) Vol. 117 Issue 3 Pg. c276-83 ( 2011) ISSN: 1660-2110 [Electronic] Switzerland
PMID20847570 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 S. Karger AG, Basel.
Chemical References
  • Uric Acid
Topics
  • Adult
  • Cardiovascular Diseases (blood, diagnosis, etiology)
  • Female
  • Follow-Up Studies
  • Graft Rejection (blood, diagnosis, etiology)
  • Graft Survival (physiology)
  • Humans
  • Hyperuricemia (blood, diagnosis, etiology)
  • Kidney Transplantation (adverse effects, physiology)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Time Factors
  • Uric Acid (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: